Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Immune cells affect hair growth and could lead to new hair loss treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

IGF-1 affects hair loss and could be a potential treatment.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Ozone therapy might improve cancer treatment and reduce its side effects.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Substance from human umbilical cord blood cells promotes hair growth.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Mice with autoimmune hair loss showed signs of heart problems.